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Abstract  
BACKGROUND: In the past several decades, the increasing frequency of overweight and obese children and 
adolescents in the world has become a public health problem. It has contributed significantly to the already high 
tide of diabetes, cardiovascular and cerebrovascular diseases.  
AIM: To investigate the frequency of insulin resistance and to evaluate the metabolic profile of insulin resistant 
and non-insulin resistant obese children and adolescents. 
SUBJECTS AND METHODS: The study included 96 (45 boys, 51 girls) obese children and adolescents aged     
4-17 years old (10.50 ± 2.87 years). Only participants with Body Mass Index ≥ 95 percentile were included.  We 
analysed sera for fasting insulin levels (FI), fasting serum triglycerides (TG), total serum cholesterol (TC), fasting 
plasma glucose (FPG) and plasma glucose 2 hours after the performance of the oral glucose tolerance test        
(2-h G). Homeostatic model assessment for insulin resistance (HOMA-IR) index was calculated as fasting insulin 
concentration (microunits per millilitre) x fasting glucose concentration (millimolar)/22.5. The value of HOMA-IR 
above 3.16 was used as a cut-off value for both genders.  
RESULTS: Insulin resistance was determined in 58.33% of study participants. Insulin resistant participants had 
significantly higher level of 2-h G (p = 0.02), FI level (p = 0.000) as well as TG levels (p = 0.01), compared to non-
insulin resistant group. Strikingly, 70.73% of the pubertal adolescents were insulin resistant in comparison to 
49.09% of the preadolescents (p = 0.03). Significantly higher percentage of insulin-resistant participants were girls 
(p = 0.009). Moreover, a higher percentage of the girls (70.59%) than boys (44.44%) had HOMA-IR above 3.16 
and had elevated FI levels (70.59% vs 48.89%). The difference in the frequency of insulin resistance among 
obese versus severely obese children and adolescents was not significant (p = 0.73, p > 0.05). Our study results 
also showed positive, but weak, correlation of HOMA-IR with age, FPG, TG and BMI of the participants (p < 0.05).  
CONCLUSION: Higher percentage of insulin-resistant participants was of female gender and was adolescents. In 
general, insulin resistant obese children and adolescents tend to have a worse metabolic profile in comparison to 
individuals without insulin resistance. It is of note that the highest insulin resistance was also linked with the 
highest concentrations of triglycerides. 
 
 
 
 
 
Introduction 
 
Obesity is a chronic medical condition where 
increased adipose tissue growth impairs metabolic 
health, increases the risk for type 2 diabetes mellitus, 
cardiovascular diseases, dyslipidemia, hypertension 
and insulin resistance [1] [2] [3] [4] [5].  
Obesity rates are constantly rising globally, in 
line with growing prevalence of obesity and 
overweight in pediatric patients. This prevalence has 
risen by 47.1% between 1980 and 2013 [6]. One in 3 
children in the US is overweight or obese [7]. In 
Europe, the highest rates of obese children are 
observed in the south-eastern European countries [8]. 
Also, the rise in obesity is occurring in earlier ages [9] 
[10]. It is of note there has been plateauing in the 
prevalence of obesity in developed countries [11].  
Insulin resistance is a key component of the 
metabolic syndrome [12]. Childhood insulin resistance 
could impair metabolic health and is associated with 
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metabolic syndrome, prediabetes, type 2 diabetes 
mellitus and several other cardiometabolic risk factors 
[13][5]. One of the earliest complications, as a 
consequence of insulin resistance in childhood 
obesity, is the impairment of glucose metabolism [14]. 
However, it should be mentioned that insulin 
resistance may not always be present in obese 
individuals [13]. 
There are several methods that could be used 
for assessing insulin resistance: hyperinsulinemic 
euglycemic clamp and intravenous glucose tolerance 
test, homeostasis model assessment (HOMA), 
quantitative insulin sensitivity check index (QUICKI), 
McAuley index, Matsuda index, Belfioreindex, 
Cederholm index, Avignonindex, Stumvollindex. 
Although hyperinsulinaemic-euglycaemic clamp test is 
the gold-standard for the measurement of insulin 
sensitivity, homeostatic model assessment has been 
considered as a useful, cost-effective, and most 
widely used tool for the assessment of insulin 
resistance [15] [16]. The interaction between HOMA-
IR and BMI in preadolescence predicts the likelihood 
of having metabolic syndrome in late adolescence. 
Therefore reducing insulin resistance in children at the 
age of 9-10 years could lead to metabolic syndrome 
prevention at the age of 18-19 years [17]. Moreover, 
both metabolic syndrome and type 2 diabetes mellitus 
in adulthood could be predicted form the existence of 
pediatric metabolic syndrome [18]. Impaired fasting 
glucose, type 2 diabetes mellitus in early adulthood 
could also be predicted using the HOMA-IR index for 
insulin resistance in the preadolescent age [19]. 
However, it is the HOMA-IR threshold levels for 
defining insulin resistance have been varying greatly 
hampering the interpretation of the results [20].  
Our study aimed to investigate the frequency 
of insulin resistance and to evaluate the metabolic 
profile of insulin resistant and non-insulin resistant 
obese children and adolescents. 
 
 
Methods  
 
This cross-sectional study included a total of 
96 obese children and adolescents referred to the 
University Clinic of Child Diseases – Skopje between 
2009 and 2017 for investigation and treatment for 
obesity. The cohort included 45 boys and 51 girls 
aged 4-17 years (10.50 ± 2.87). Study participants 
were classified as preadolescents if they were 
between 4 and 11 years old and adolescents if they 
were between 12 and 18 years old [21]. Obesity was 
the only inclusion criteria, as defined from the sex- 
and age-specific growth charts provided by the 
Centers of Disease Control and Prevention (CDC) – 
Body Mass Index ≥ 95th percentile [22]. As severely 
obese participants were classified those whose BMI 
was 120% of the 95
th
 percentile for age and sex [23].  
Study participants with secondary obesity syndromes, 
syndromal obesity, primary hyperinsulinemia, 
hypothyroidism, long-term corticosteroid use, primary 
hyperlipidemia, diabetes mellitus type 1, or other 
weight affecting disorders as well as chronic, 
hereditary, endocrine, infectious and inflammatory 
disorders were excluded. This study was approved by 
the Ethical Committee of the Faculty of Medicine of 
the University “Ss. Cyril and Methodius” – Skopje, 
Macedonia and was carried out by the Declaration of 
Helsinki.   
Participants’ height (to the nearest millimetre) 
and weight (to the nearest decimal fraction of kg) were 
measured according to the standard procedures while 
participants’ were barefoot and dressed only in light 
underwear. Body Mass Index was calculated as 
weight in kilograms divided by height in square 
meters. An oral glucose tolerance test was performed 
with a dose of 1.75 g glucose/kg body weight (up to a 
maximum of 75 grams) by the World Health 
Organization (WHO) recommendations [24]. Blood 
samples were collected in at 0 minutes and in several 
intervals, at 30, 60, 90, 120, 150, 240 minutes, after 
the glucose load.  All study participants fasted for 12 
hours after which venous sampling was done. The 
levels of plasma glucose, serum triglycerides, and 
total serum cholesterol were determined using clinical 
chemistry analyser ARCHITECT c4000 (Abbott 
Diagnostics). Insulin levels were measured in an 
analyser IMMULITE® 2000 immunoassay system 
(SimensHealthcareDiagnostics). Homeostatic model 
assessment for insulin resistance (HOMA-IR) index 
was calculated: fasting insulin concentration 
(microunits per millilitre) x fasting glucose 
concentration (millimolar)/22.5 [25].  
Serum fasting triglyceride levels ≥ 100 
(mg/dL) for children aged 0-9 years and > 130 for 
children aged 10-19 years old defined the abnormally 
elevated level of serum triglycerides. Total serum 
cholesterol ≥ 200 mg/dL was considered abnormal 
[26]. To convert mg/dL to mmol/L values of total 
cholesterol and triglycerides were multiplied by 0.0259 
and 0.0113, respectively; 
Impaired fasting glucose was defined if the 
fasting plasma glucose level was ≥ 5.6 but < 7 
mmol/L, impaired glucose tolerance if two-hours of 
plasma glucose after OGTT performance was ≥ 7.8 
but < 11.1 mmol/L. Type 2 diabetes mellitus was 
defined if the fasting plasma glucose level was ≥ 7 
mmol/L, or two -hours of plasma glucose after OGTT 
performance was ≥ 11.1 mmol/L [27]. Fasting insulin 
levels ≥ 15 mU/ml were considered hyperinsulinemic 
levels [28]. Insulin resistance was defined as HOMA-
IR index > 3.16 [29]. 
Continuous data were expressed as mean ± 
SE. Categorical data were expressed as frequencies 
and percentages. All continuous variables were first 
tested for distribution normality using Smirnov -
Kolmogorov and Shapiro-Wilk normality tests. 
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Depending on the normality of the distribution 
parametric and non-parametric statistical tests were 
conducted. For the analysis of normally distributed 
data t-test was performed and Pearson correlation 
coefficients were calculated. In cases where data 
were not normally distributed Man Whitney U test was 
conducted, and Spearman correlation coefficients 
were calculated. The Pearson Chi-square was used to 
analyse differences in categorical variables. Data 
were analyzed by using statistical package 
STATISTICA 8.0. P values < 0.05 were considered 
statistically significant. 
 
 
Results 
 
Our study comprised of 96 obese children and 
adolescents (45 boys and 51 girls), aged between 4 -
17 years (Table 1). Girls had significantly higher BMI, 
fasting insulin levels and HOMA-IR compared to boys 
(p < 0.005). Other metabolic parameters (fasting 
plasma glucose, plasma glucose 2 hours post the 
glucose load after the OGTT, total cholesterol and 
triglyceride level) did not differ significantly between 
genders (Table 1). 
Table 1: Clinical and metabolic characteristics of obese 
children and adolescents according to gender 
  All Boys Girls  
 
p-
value 
Variable Participants 
No. 
% or 
mean  
± SE 
Participants 
No. 
% or 
mean  
± SE 
Participants 
No. 
% or 
mean  
± SE 
Degree of 
obesity* 
96 - 45 - 51 - 0.45
1 
Obese 27 28.13 11 24.44 16 31.37  
Severely obese 69 71.88 34 75.56 35 68.63  
        
Preadolescents 
vs. 
adolescents* 
96 - 45 - 51 - 0.03
2 
Preadolescents 55 57.29 31 68.89 24 47.06  
Adolescents 41 42.71 14 31.11 27 52.94  
        
Age (years)
††
 96 10.50 ± 
0.29 
45 10.17 ± 
0.40 
51 10.79 ± 
0.42 
0.18 
Wieght (kg)
††
 96 74.97 ± 
2.39 
45 72.86 ± 
3.73 
51 76.84 ± 
3.08 
0.18 
Height (cm)
††
 96 150.52 
± 1.63 
45 149.20 
±2.68 
51 151.69 
± 2.03 
0.45 
BMI (kg/m
2
)
††
 96 31.68 ± 
0.49 
45 30.63 ± 
0.58 
51 32.62 ± 
0.74 
0.03 
FPG (mmol/L)
†
 96 4.18 ± 
0.04 
45 4.16 ± 
0.07 
51 4.20 ± 
0.06 
0.65 
2-h G (mmol/L)
†
 93 5.67 ± 
0.12 
45 5.70 ± 
0.18 
48 5.64 ± 
0.16 
0.79 
FI (uU/mL)
††
 96 20.35 ± 
1.09 
45 16.93 ± 
1.46 
51 23.37 ± 
1.47 
0.000 
HOMA-IR
††
 96 3.80 ± 
0.21 
45 3.14 ± 
0.29 
51 4.37 ± 
0.29 
0.000 
TC (mmol/L)
†
 88 4.05 ± 
0.08 
41 4.04 ± 
0.12 
47 4.06 ± 
0.10 
0.89 
TG (mmol/L)
††
 88 1.20 ± 
0.06 
41 1.11 ± 
0.09 
47 1.27 ± 
0.07 
0.07 
*Obtained from 
2
 test for comparison of categorical variables; 
†
Group comparison was 
examined using Mann-Whitney U test for continuous data;
††
Group comparison was 
examined using t test for continuous data; 
1
Pearson 
2 
= 0.57, df=1; 
2
Pearson 
2 
= 4.66, 
df=1; BMI, Body Mass Index; FPG, fasting plasma glucose; 2-h G, plasma glucose two 
hours post the glucose load during the oral glucose tolerance test; FI, fasting insulin level; 
HOMA-IR, homeostatic model assessment of insulin resistance; TC, total cholesterol; TG, 
triglycerides. 
 
The second table shows characteristics of 
insulin resistant and non-insulin resistant obese 
children and adolescents. Adolescents had a 
statistically significant higher frequency of insulin 
resistance (p = 0.03). Also, the significantly higher 
percentage of participants with insulin resistance were 
girls compared to boys (64.29% vs 35.71%, p = 
0.009). The mean age, as well as BMI, was 
significantly higher in the insulin-resistant group (p < 
0.05). Study participants who had insulin resistance 
had significantly higher values of some of the 
metabolic parameters (plasma glucose 2 hours post 
the glucose load after the OGTT, fasting insulin, level 
of triglycerides) compared to participants in the non-
resistant group.  The values of fasting plasma glucose 
and total serum cholesterol showed no statistically 
significant difference between the two tested groups.  
Table 2: Clinical and metabolic characteristics of obese 
children and adolescents according to insulin resistance 
  Non-insulin resistant 
(non-IR) 
Insulin resistant (IR)  
 
p-value Variable Participants 
No. 
Participants 
No. 
% or 
mean  
± SE 
Participants 
No. 
% or 
mean  
± SE 
Degree of 
obesity* 
96 40 - 56 - 0.73
1 
Obese 27 12 30.00 15 26.79  
Severely obese 69 28 70.00 41 73.21  
       
Preadolescents 
vs. adolescents* 
96 40 - 56 - 0.03
2
 
Preadolescents 55 28 70.00 27 48.21  
Adolescents 42 12 30.00 29 51.79  
       
Gender      0.009
3
 
Boys 45 25 62.5 20 35.71  
Girls 51 15 37.5 36 64.29  
       
Age (years)
††
 96 40 9.79 ± 
0.50 
56 11.00 ± 
0.34 
0.04 
Wieght (kg)
††
 96 40 67.05 ± 
3.21 
56 80.63 ± 
3.21 
0.005 
Height (cm)
††
 96 40 146.76 ± 
2.64 
56 153.21 ± 
2.02 
0.03 
BMI (kg/m
2
)
††
 96 40 30.35 ± 
0.63 
56 32.64 ± 
0.68 
0.02 
FPG (mmol/L)
†
 96 40 4.09 ± 
0.07 
56 4.25 ± 
0.06 
0.07 
2-h G (mmol/L)
†
 93 39 5.35 ± 
0.19 
54 5.89 ± 
0.15 
0.02 
FI (uU/mL)
††
 96 40 11.81 ± 
0.59 
56 26.45 ± 
1.30 
0.000 
TC (mmol/L)
†
 88 35 3.88 ± 
0.11 
53 4.15 ± 
0.10 
0.08 
TG (mmol/L)
††
 88 35 0.99 ± 
0.07 
53 1.33 ± 
0.08 
0.005 
*Obtained from 2 test for comparison of categorical variables; 
†
Group comparison was 
examined using Mann-Whitney U test for continuous data;
††
Group comparison was 
examined using t-test for continuous data; 
1
Pearson 
 2 
= 0.12, df=1; 
2
Pearson 
 2 
= 4.53, 
df=1; 
3
Pearson 
 2 
= 6.72, df=1; BMI, Body Mass Index; FPG, fasting plasma glucose; 2-h 
G, plasma glucose two hours post the glucose load during the oral glucose tolerance test; 
FI, fasting insulin level; TC, total cholesterol; TG, triglycerides. 
 
On Table 3 are demonstrated percentages of 
abnormal metabolic parameters among study 
participants by gender and insulin resistance status 
according to HOMA-IR. The frequency of elevated 
fasting insulin levels was significantly higher in girls (p 
= 0.03). The distribution of other metabolic parameters 
between boys and girls did not reveal any statistical 
significance. The percentage of abnormal level of 
fasting insulin was significantly higher in obese 
insulin-resistant children and adolescents. Also, the 
elevated triglycerides level was more prevalent in the 
insulin-resistant group. However, the differences in 
the distribution of other abnormal laboratory 
parameters among study participants showed no 
statistical significance.  
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Table 3: Frequency (%) of abnormal laboratory parameters among study participants 
   Gender HOMA-IR 
  All Boys Girls  
 
p-value* 
Non-insulin resistant (non-
IR) 
Insulin resistant 
(IR) 
 
 
p-value* Variable Participants 
No. 
n (%) Participants 
No. 
n (%) Participants 
No. 
n (%) Participants 
No. 
n (%) Participants 
No. 
n (%) 
FPG 
(mmol/L) 
96 1 (1.04) 45 1 (2.22) 51 0 (0.00) 0.28
1 
40 0 (0.00) 56 1 (1.79) 0.40
7
 
2-h G 
(mmol/L) 
93 3 (3.23) 45 1 (2.22) 48 2 (4.17) 0.60
2 
39 2 (5.13) 54 1 (1.85) 0.38
8
 
FI (uU/ml) 96 58 (60.42) 45 22 (48.89) 51 36 (70.59) 0.03
3
 40 5 (12.5) 56 53 (96.64) 0.000
9
 
TC (mmol/L) 88 5 (5.68) 41 3 (7.32) 47 2 (4.26) 0.75
4
 35 2 (5.71) 53 3 (5.66) 0.27
10
 
TG (mmol/L) 88 30 (34.09) 41 13 (31.71) 47 17 (36.17) 0.10
5
 35 9 (25.71) 53 21 (39.62) 0.01
11
 
HOMA-IR 96 56 (58.33) 45 20 (44.44) 51 36 (70.59) 0.009
6
 - - - - - 
*Obtained from 
2
 test for comparison of categorical variables; 
1
Pearson 
2 
= 1.15, df=1; 
2
Pearson 
2 
= 0.28, df=1;
 3
Pearson 
2 
= 4.71, df=1; 
4
Pearson 
2 
= 0.57, df=2; 
5
Pearson 
2 
= 4.57, 
df=2; 
6
Pearson 
2 
= 6.72, df=1; 
7
Pearson 
2 
= 0.72, df=1; 
8
Pearson 
2 
= 0.78, df=1; 
9
Pearson 
2 
= 65.83, df=1; 
10
Pearson 
2 
= 2.60, df=2;  
11
Pearson 
2 
= 8.75, df=2; FPG, fasting plasma 
glucose; 2-h G, plasma glucose two hours post the glucose load during the oral glucose tolerance test; FI, fasting insulin level; TC, total cholesterol; TG, triglycerides; HOMA-IR, 
homeostatic model assessment of insulin resistance. 
 
On Figure 1 the differences and the frequency 
of abnormal metabolic parameters between 
participants in two age groups (preadolescents: 4-12; 
adolescents: ≥ 12-18 years) are presented. There was 
a higher percentage of plasma glucose 2 hours post 
the glucose load after the OGTT, elevated fasting 
insulin and HOMA-IR among adolescents in 
comparison to preadolescents. All adolescents have 
undergone puberty, in contrast to only 15% of the 
preadolescents. 
 
Figure 1: Distribution of abnormal parameters among study 
participants according to age group. FI, fasting insulin level; HOMA-
IR, homeostatic model assessment for insulin resistance. †p value 
< 0.05, preadolescents vs. adolescents 
 
As shown in Figure 2, the comparison of 
HOMA-IR comparing the degree of obesity did not 
reveal any statistical significance (p > 0.05).  
 Median 
 25%-75% 
 Min-Max 
OBESE SEVERELY OBESE
0
2
4
6
8
10
12
H
O
M
A
-I
R
            HOMA-IR
        p>0.05, p=0.46
n: 27 n: 69
 
Figure 2: Homeostatic model assessment of insulin resistance 
comparison between obese and severely obese children and 
adolescents 
 
Figure 3 shows differences in the frequency of 
insulin resistance (HOMA – IR > 3.16) among obese 
and severely obese participants. There was no 
statistical significance in the distribution of insulin 
resistance between two examined groups (p = 0.73, 
Pearson χ
2 
= 0.12, df = 1). 
 
Figure 3: Frequency (%) of elevated HOMA-IR according to the 
degree of obesity. HOMA-IR, homeostatic model assessment for 
insulin resistance. p-value > 0.05, obese vs. severely obese 
 
Correlation analysis between the BMI and 
HOMA-IR of the participants with age and other 
investigated metabolic parameters is presented in 
Table 4. BMI was positively correlated with age, FI 
and HOMA IR of the participants, while HOMA-IR 
showed a positive correlation with age, fasting plasma 
glucose, fasting insulin, triglycerides, and BMI.  
Table 4: Correlation between Body Mass Index and HOMA-IR 
with various parameters studied 
  Body Mass Index HOMA-IR 
Variable n Correlation 
coefficient 
p-value Correlation 
coefficient 
p-value 
Age (years)
 ††
 96 0.62 0.000 0.29 0.005 
FPG (mmol/L)
 †
 96 0.02 0.80 0.24 0.02 
2-h G (mmol/L)
 †
 93 0.13 0.22 0.20 0.06 
FI (uU/mL)
 ††
 96 0.34 0.000 0.98 0.00 
TC (mmol/L)
 †
 88 -0.003 0.98 0.17 0.12 
TG (mmol/L)
 ††
 88 0.16 0.14 0.38 0.000 
BMI (kg/m
2
)
 ††
 96 - - 0.33 0.001 
HOMA-IR
††
 96 0.33 0.001 - - 
†
Correlation examined using Pearson correlation, 
†† 
Correlation examined using Spearman 
correlation; FPG, fasting plasma glucose; 2-h G, plasma glucose two hours post the 
glucose load during the oral glucose tolerance test; FI, fasting insulin level; TC, total 
cholesterol; TG, triglycerides; BMI, Body Mass Index; HOMA-IR, homeostatic model 
assessment of insulin resistance. 
 
 
Discussion 
 
Studies have shown an association of excess 
adipose tissue with insulin resistance [30]. In the 
present study, 58.13% of all participants were insulin 
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resistant. Significantly higher percentage of girls 
(70.59%) was insulin resistant in comparison with 
boys (44.44%). A high percentage of insulin 
resistance among children and adolescents is also 
evident in other studies [31] [32]. Others have also 
reported that there is a significantly higher percentage 
of girls with insulin resistance [33]. The concentrations 
of plasma insulin and HOMA-IR indicating insulin 
resistance were not significantly higher in girls [34]. A 
study that aimed to evaluate possible predictors for 
fasting insulin levels in overweight and obese 
adolescents concluded that gender, BMI and waist 
circumference were predictors of fasting insulin and 
HOMA-IR. In the same study, girls were considered to 
have higher fasting insulin levels compared to boys 
[32], which is by our study results.Similarly, the level 
of serum insulin showed high association with female 
gender in a study conducted by Hrafnkelsson et al. 
[35]. Results from another study from the United 
Kingdom revealed that 5 years old girls were more 
prone to be insulin resistant compared to their peers 
of the opposite gender [36]. A study conducted on 
3,203 children and adolescents from China showed 
that those participants with the highest number of 
metabolic abnormalities had significantly higher 
HOMA-IR [31]. Insulin resistance was significantly 
higher in girls [37]. 
We found a significant difference in gender 
distribution between IR and non-IR group. Namely, 
64.29% of the IR group were girls, and 35.71% were 
boys, while 37.5% and 62.5% of the non-IR group 
were girls and boys, respectively. Thus, the 
percentage of girls was higher in the group of children 
and adolescents with insulin resistance. In the current 
study, obese girls were not found to have significantly 
higher values of triglycerides. Also, the frequency of 
abnormal triglyceride level was not significantly 
different compared to obese boys. Different studies 
have shown that insulin resistance could lead to 
various abnormalities affecting lipid and lipoprotein 
levels [2]. Contrary to our study, triglyceride levels 
were highly associated with female gender and were 
significantly higher in girls [35]. The study conducted 
on 151 overweight youths found that triglycerides 
level, as a cardiovascular risk factor, increased with 
the increase of fasting insulin as well as with the 
increase of 2 hours insulin [38]. A significant positive 
correlation between the level of triglycerides and 
fasting insulin and HOMA-IR has been confirmed in a 
study on overweight and obese adolescents [32]. 
Children who had insulin levels in the highest quartile 
showed increased levels of various cardiovascular risk 
factors such as triglycerides, systolic and diastolic 
blood pressure, LDL-cholesterol, VLDL cholesterol, 
glucose, and decreased the level of HDL-cholesterol. 
These children also showed higher BMI [39]. 
Because 52.94% of the girls were in the 
adolescent age, while 68.89% of the boys were in the 
preadolescent age, these differences in the insulin 
resistance status in girls might be related to the age of 
the participants. Namely, significantly higher 
percentage (51.79%) of the study participants with 
insulin resistance were adolescents and 70% of the 
non-IR group were preadolescents. Our study 
indicated that insulin-resistant participants had higher 
BMI and were older. Similarly, the mean age and BMI 
of study participants with IR were found to be higher 
compared to those without IR in a study conducted by 
Romualdo et al. [33]. One study on 196 obese 
children and adolescents from Turkey revealed that 
the frequency of cases with insulin resistance differs 
significantly between the prepubertal and pubertal 
group and that it is higher among obese adolescents 
[40]. This is also our observation. One of the most 
relevant longitudinal studies that was investigating 
insulin resistance in different stages of puberty on 357 
normal children and adolescents found that up to the 
Tanner stage 2 insulin resistance increases, while 
during Tanner stages 2, 3 and 4 is constant, followed 
by a decrease in the prepubertal level at the Tanner 
stage 5 [37]. Similarly, another recent study suggests 
that insulin resistance is under the influence of 
puberty only in Tanner Stage (TS) 1, while during TS 
2-4, insulin resistance did not reveal such association. 
Authors discuss that it could be a result of the degree 
of obesity, as a contributor to the development of 
insulin resistance, during adolescence. Therefore, 
screening for IR is highly recommended in children 
with early puberty onset, as well as, in adolescents 
with obesity [41]. However, the suggested insulin 
sensitivity recovery phenomenon in lean children at 
the end of puberty could not be seen in obese 
individuals [42] [43]. Insulin resistance during puberty 
in obese children is even higher than normal -weight 
controls [43]. Furthermore, the above-discussed 
decrease in insulin sensitivity has been shown to start 
before the pubertal transition in children with morbid 
obesity, and this could not be explained by total 
adiposity status [44].  Others have demonstrated that 
metabolically healthy obese children tend to change to 
metabolically unhealthy when growing from pre-
pubertal to pubertal stage. The metabolic set up in 
girls could be under the influence of hormonal 
changes during puberty and adolescence or due to 
gender-specific body fat distribution [32]. It has been 
discussed that insulin resistance is not always a 
consequence of obesity, but it could also be a 
contributing factor that leads to its development [31]. 
In the USA more than 50% of the adolescents with 
obesity are insulin resistant [45]. In girls, insulin 
resistance occurring during puberty could be 
worsening as a result of existing obesity [46].  
In the current study, an obvious unfavourable 
metabolic profile was noticed among insulin-resistant 
participants compared to the non-insulin resistant 
group. More precisely, participants in the IR group had 
higher values of all investigated laboratory parameters 
such as: fasting plasma glucose, 2-h plasma glucose, 
fasting insulin, and total serum cholesterol and 
triglyceride level. However, significant differences 
were only seen in 2-h plasma glucose, fasting insulin 
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and triglyceride levels. Moreover, the frequency of 
abnormal fasting insulin and triglycerides was higher 
among insulin-resistant participants. Strikingly, 
96.64% and 39.62% of insulin-resistant participants 
tend to have elevated levels of fasting insulin and 
serum triglycerides, respectively. Only for comparison, 
the percentage of abnormal fasting insulin and serum 
triglycerides in the non-insulin resistant group was 
12.5% and 25.71% respectively. In one study it has 
been shown that glucose and insulin levels among 
obese participants with elevated HOMA-IR (> 2.5) 
were significantly higher compared to the obese 
children with HOMA-IR below 2.5. Interestingly, these 
same differences were found in the non-obese 
participants with HOMA-IR > 2.5 and HOMA-IR < 2.5. 
In contrary to our results, in obese and non - an obese 
group with HOMA-IR < 2.5 or HOMA-IR > 2.5 
participants’ BMI values did not differ significantly [47]. 
Our study results are similar to those of Atabek et al. 
[40] whereas insulin resistant group of obese children 
have significantly higher mean age, higher BMI, 
fasting glucose, fasting insulin levels and HOMA-R. 
Triglyceride levels and total cholesterol levels were 
not found to differ significantly between these two 
groups. In Another study, triglyceride levels were 
significantly higher in participants with insulin 
resistance [33]. The differences between triglyceride 
levels were significantly higher in the groups of obese 
children and adolescents with insulin resistance 
compared to non-insulin resistant groups [41] [48].  
The present study indicates that, although 
weakly, the HOMA-IR was positively correlated with 
the age, fasting plasma glucose levels, triglyceride 
levels, and BMI of the participants. Similarly, a study 
conducted by Esteghamati et al. [49], showed a 
positive correlation between HOMA-IR and BMI in all 
subjects as well as in different study groups 
considering the degree of obesity. Our study revealed 
the strong positive correlation between HOMA-IR and 
fasting insulin levels in study participants. A study that 
evaluated the correlation of insulin resistance 
assessed by different indices such as McAuley, 
HOMA and QUICKI, came to a conclusion that fasting 
insulin is sensitive and could be used as a simple test 
for the detection of insulin resistance in obese 
individuals [50]. Thus, it could be concluded that 
obese insulin-resistant individuals show significantly 
worse metabolic profile compared to non-insulin 
resistant ones. 
Interestingly, 2.22% of boys from our study 
had impaired fasting glucose, while girls were not 
affected. On the contrary, impaired glucose tolerance 
was detected in 4.17% of girls, while the percentage 
of boys remained unchanged 2.22%. The study of 
Valerio et al. [51], did not detect any case of impaired 
fasting plasma glucose, presenting this laboratory 
parameter as insensitive. However, this same study 
found 4% prevalence of impaired glucose tolerance 
among the study population of obese children and 
adolescents. Our results are consistent with a study in 
which impaired fasting glucose was detected only in 
boys (3%), while no cases were detected in girls. 
Similarly, the percentage of impaired glucose 
tolerance among girls increased dramatically and was 
equal to the one among boys (11%) [52]. 
Hagman et al. in her studies pointed out those 
regional differences in glucose levels exist. A study 
that compared the plasma glucose level between 
Swedish and Polish children concluded that obese 
Swedish children have higher glucose levels in 
comparison to obese children from Poland [53]. Also, 
the risk of having impaired plasma glucose is higher in 
obese children from Sweden compared to obese 
children in Germany [54]. Another study conducted on 
54 obese children confirmed that obese children with 
insulin resistance have higher blood sugar level 
compared to those obese children without insulin 
resistance [55]. Interestingly, it has been suggested 
that the risk of having impaired glucose tolerance is 
higher in obese children who have high fasting blood 
glucose level, but still in the range of the reference 
values [56].  
Data from our study showed that the 
frequency of impaired fasting glucose, as well as 
impaired glucose tolerance 2 hours post oral glucose 
tolerance test performance, in both IR and non-IR 
group, were low. Only 1.79% insulin-resistant 
participants showed impaired fasting glucose. 
Similarly, 1.85% and 5.13% had impaired glucose 
tolerance in IR and non-IR study group, respectively. 
There were no cases of type 2 diabetes mellitus 
detected. Our results did not reveal a significant 
difference between plasma glucose level between IR 
and non-IR group. Although the prevalence of type 2 
diabetes is low, studies have shown that there is a 
significant increase in recent years, especially with the 
increase in the prevalence of obesity [57]. 
Considering the degree of obesity, HOMA-IR 
values, as well as all other metabolic parameters, did 
not differ significantly between severely obese and 
obese participants. However, although differences 
between these two categories of obesity regarding 
insulin resistance did not reveal significance, it is 
worth mentioning that insulin resistance is high among 
obese and severely obese participants. Namely, 
55.56% of obese and 59.42% of severely obese 
children and adolescents in our study were insulin 
resistant. The high percentage of insulin resistance 
among obese children is also seen in studies from the 
literature. Insulin resistance was found in 44.3% [52], 
40.8% in obese children and 41.2% in obese 
adolescents [51]. A study on forty obese patients 
revealed that the degree of omental white adipose 
tissue fibrosis in severe obesity might be the 
explanation for the degree of insulin resistance in 
severely obese individuals [58]. A study found that 
serum insulin levels were higher among overweight 
children compared to normal weight children [35]. 
Importantly, the metabolic profile between overweight 
and obese subjects might not always lead to 
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significant differences, indicating that metabolic 
disturbances are already present in the overweight 
state [59].  
We found that obese children and 
adolescents have a high rate of insulin resistance and 
have altered biochemical metabolic parameters. Lack 
of control group and relatively small sample size were 
major drawbacks of this study, therefore imposing that 
these data need to be confirmed in a controlled trial in 
order more relevant clinical conclusions to be drawn. 
In conclusion, insulin resistance is highly 
prevalent among obese children and adolescents. 
Interestingly, the degree of obesity does not seem to 
play an important factor. Significantly higher 
percentage of insulin-resistant participants was girls. 
Also, the frequency of insulin resistance was higher 
among adolescents. Obese individuals with insulin 
resistance show more unfavourable metabolic setup, 
with higher BMI, plasma glucose two-hour post 
glucose load during the OGTT and higher levels and 
frequency of abnormal serum triglycerides. It is of note 
that the more pronounced insulin resistance was also 
linked with the highest concentrations of triglycerides.  
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